Journal of Biological Chemistry · 2005 · 70 citations · 54 references
Life SciencesBiochemistryEndocrinologyGene ExpressionHormone BiochemistryMetabolic RegulationDiabetes MellitusEndocrine SignalingHormone SecretionPancreatic EndocrinologyPancreatic HormonesRodent EndocrinologyEndocrine Pancreatic FunctionGlucose-stimulated Insulin SecretionIslet Cell MassPancreatic Hormone SecretionPancreatic Islet ArchitecturePancreatic Islet SecretionPancreatic Peptide HormonesTransgenic Mice
We developed and analyzed two types of transgenic mice: rat insulin II promoter-ghrelin transgenic (RIP-G Tg) and rat glucagon promoter-ghrelin transgenic mice (RGP-G Tg). The pancreatic tissue ghrelin concentration measured by C-terminal radioimmunoassay (RIA) and plasma desacyl ghrelin concentration of RIP-G Tg were about 1000 and 3.4 times higher than those of nontransgenic littermates, respectively. The pancreatic tissue n-octanoylated ghrelin concentration measured by N-terminal RIA and plasma n-octanoylated ghrelin concentration of RIP-G Tg were not distinguishable from those of nontransgenic littermates. RIP-G Tg showed suppression of glucose-stimulated insulin secretion. Arginine-stimulated insulin secretion, pancreatic insulin mRNA and peptide levels, β cell mass, islet architecture, and GLUT2 and PDX-1 immunoreactivity in RIP-G Tg pancreas were not significantly different from those of nontransgenic littermates. Islet batch incubation study did not show suppression of insulin secretion of RIP-G Tg in vitro. The insulin tolerance test showed lower tendency of blood glucose levels in RIP-G Tg. Taking lower tendency of triglyceride level of RIP-G Tg into consideration, these results may indicate that the suppression of insulin secretion is likely due to the effect of desacyl ghrelin on insulin sensitivity. RGP-G Tg, in which the pancreatic tissue ghrelin concentration measured by C-RIA was about 50 times higher than that of nontransgenic littermates, showed no significant changes in insulin secretion, glucose metabolism, islet mass, and islet architecture. The present study raises the possibility that desacyl ghrelin may have influence on glucose metabolism. We developed and analyzed two types of transgenic mice: rat insulin II promoter-ghrelin transgenic (RIP-G Tg) and rat glucagon promoter-ghrelin transgenic mice (RGP-G Tg). The pancreatic tissue ghrelin concentration measured by C-terminal radioimmunoassay (RIA) and plasma desacyl ghrelin concentration of RIP-G Tg were about 1000 and 3.4 times higher than those of nontransgenic littermates, respectively. The pancreatic tissue n-octanoylated ghrelin concentration measured by N-terminal RIA and plasma n-octanoylated ghrelin concentration of RIP-G Tg were not distinguishable from those of nontransgenic littermates. RIP-G Tg showed suppression of glucose-stimulated insulin secretion. Arginine-stimulated insulin secretion, pancreatic insulin mRNA and peptide levels, β cell mass, islet architecture, and GLUT2 and PDX-1 immunoreactivity in RIP-G Tg pancreas were not significantly different from those of nontransgenic littermates. Islet batch incubation study did not show suppression of insulin secretion of RIP-G Tg in vitro. The insulin tolerance test showed lower tendency of blood glucose levels in RIP-G Tg. Taking lower tendency of triglyceride level of RIP-G Tg into consideration, these results may indicate that the suppression of insulin secretion is likely due to the effect of desacyl ghrelin on insulin sensitivity. RGP-G Tg, in which the pancreatic tissue ghrelin concentration measured by C-RIA was about 50 times higher than that of nontransgenic littermates, showed no significant changes in insulin secretion, glucose metabolism, islet mass, and islet architecture. The present study raises the possibility that desacyl ghrelin may have influence on glucose metabolism. Ghrelin is a 28-amino acid peptide with unique modification of acylation, which is essential for its biological action (1Kojima M. Hosoda H. Date Y. Nakazato M. Matsuo H. Kangawa K. Nature. 1999; 402: 656-660Crossref PubMed Scopus (7317) Google Scholar). Ghrelin was originally identified in rat stomach as an endogenous ligand for an orphan receptor, which has been so far called growth hormone secretagogue receptor (GHS-R) 1The abbreviations used are: GHS-R, growth hormone secretagogue receptor; RIP-G Tg, rat insulin II promoter-ghrelin transgenic; RGP-G Tg, rat glucagon promoter-ghrelin transgenic mice; RIA, radioimmunoassay; C-RIA, anti-ghrelin [13–28] antiserum; N-RIA, anti-ghrelin [1–11] antiserum; RT, reverse transcription; HDL, high density lipoprotein; PP, pancreatic polypeptide. (1Kojima M. Hosoda H. Date Y. Nakazato M. Matsuo H. Kangawa K. Nature. 1999; 402: 656-660Crossref PubMed Scopus (7317) Google Scholar). Ghrelin expression is detected in the stomach, intestine, hypothalamus, pituitary gland, kidney, placenta, and testis (2Date Y. Kojima M. Hosoda H. Sawaguchi A. Mondal M.S. Suganuma T. Matsukura S. Kangawa K. Nakazato M. Endocrinology. 2000; 141: 4255-4261Crossref PubMed Google Scholar, 3Gualillo O. Caminos J. Blanco M. Garcia-Caballero T. Kojima M. Kangawa K. Dieguez C. Casanueva F. Endocrinology. 2001; 142: 788-794Crossref PubMed Scopus (336) Google Scholar, 4Mori K. Yoshimoto A. Takaya K. Hosoda K. Ariyasu H. Yahata K. Mukoyama M. Sugawara A. Hosoda H. Kojima M. Kangawa K. Nakao K. FEBS Lett. 2000; 486: 213-216Crossref PubMed Scopus (306) Google Scholar, 5Korbonits M. Kojima M. Kangawa K. Grossman A.B. Endocrine. 2001; 14: 101-104Crossref PubMed Scopus (137) Google Scholar, 6Tena-Sempere M. Barreiro M.L. Gonzalez L.C. Gaytan F. Zhang F.P. Caminos J.E. Pinilla L. Casanueva F.F. Dieguez C. Aguilar E. Endocrinology. 2002; 143: 717-725Crossref PubMed Scopus (294) Google Scholar). Ghrelin is involved in a wide variety of the functions, including the regulation of growth hormone release, food intake, gastric acid secretion, gastric motility, blood pressure, and cardiac output (7Asakawa A. Inui A. Kaga T. Yuzuriha H. Nagata T. Fujimiya M. Katsuura G. Makino S. Fujino M.A. Kasuga M. Neuroendocrinology. 2001; 74: 143-147Crossref PubMed Scopus (314) Google Scholar, 8Masuda Y. Tanaka T. Inomata N. Ohnuma N. Tanaka S. Itoh Z. Hosoda H. Kojima M. Kangawa K. Biochem. Biophys. Res. Commun. 2000; 276: 905-908Crossref PubMed Scopus (792) Google Scholar, 9Shintani M. Ogawa Y. Ebihara K. Aizawa-Abe M. Miyanaga F. Takaya K. Hayashi T. Inoue G. Hosoda K. Kojima M. Kangawa K. Nakao K. Diabetes. 2001; 50: 227-232Crossref PubMed Scopus (781) Google Scholar, 10Seoane L.M. Tovar S. Baldelli R. Arvat E. Ghigo E. Casanueva F.F. Dieguez C. Eur. J. Endocrinol. 2000; 143: R7-R9Crossref PubMed Scopus (218) Google Scholar, 11Takaya K. Ariyasu H. Kanamoto N. Iwakura H. Yoshimoto A. Harada M. Mori K. Komatsu Y. Usui T. Shimatsu A. Ogawa Y. Hosoda K. Akamizu T. Kojima M. Kangawa K. Nakao K. J. Clin. Endocrinol. Metab. 2000; 85: 4908-4911Crossref PubMed Scopus (711) Google Scholar, 12Arvat E. Di Vito L. Broglio F. Papotti M. Muccioli G. Dieguez C. Casanueva F.F. Deghenghi R. Camanni F. Ghigo E. J. Endocrinol. Invest. 2000; 23: 493-495Crossref PubMed Scopus (359) Google Scholar, 13Date Y. Murakami N. Kojima M. Kuroiwa T. Matsukura S. Kangawa K. Nakazato M. Biochem. Biophys. Res. Commun. 2000; 275: 477-480Crossref PubMed Scopus (300) Google Scholar, 14Date Y. Nakazato M. Murakami N. Kojima M. Kangawa K. Matsukura S. Biochem. Biophys. Res. Commun. 2001; 280: 904-907Crossref PubMed Scopus (353) Google Scholar, 15Nagaya N. Uematsu M. Kojima M. Ikeda Y. Yoshihara F. Shimizu W. Hosoda H. Hirota Y. Ishida H. Mori H. Kangawa K. Circulation. 2001; 104: 1430-1435Crossref PubMed Scopus (452) Google Scholar, 16Tschop M. Smiley D.L. Heiman M.L. Nature. 2000; 407: 908-913Crossref PubMed Scopus (3411) Google Scholar, 17Wren A.M. Small C.J. Ward H.L. Murphy K.G. Dakin C.L. Taheri S. Kennedy A.R. Roberts G.H. Morgan D.G. Ghatei M.A. Bloom S.R. Endocrinology. 2000; 141: 4325-4328Crossref PubMed Google Scholar, 18Nakazato M. Murakami N. Date Y. Kojima M. Matsuo H. Kangawa K. Matsukura S. Nature. 2001; 409: 194-198Crossref PubMed Scopus (2964) Google Scholar, 19Inui A. Nat. Rev. Neurosci. 2001; 2: 551-560Crossref PubMed Scopus (348) Google Scholar). Recently Date et al. (20Date Y. Nakazato M. Hashiguchi S. Dezaki K. Mondal M.S. Hosoda H. Kojima M. Kangawa K. Arima T. Matsuo H. Yada T. Matsukura S. Diabetes. 2002; 51: 124-129Crossref PubMed Scopus (536) Google Scholar) reported that ghrelin is present in α cells of normal human and rat pancreatic islets. Volante et al. (21Volante M. Allia E. Gugliotta P. Funaro A. Broglio F. Deghenghi R. Muccioli G. Ghigo E. Papotti M. J. Clin. Endocrinol. Metab. 2002; 87: 1300-1308Crossref PubMed Scopus (303) Google Scholar) described ghrelin-expression in β cells of human islet. Wierup et al. and Prado et al. reported that ghrelin-expressing cells are a new islet cell type distinct from α, β, δ, and PP cells in human, rat, and mouse islets (22Wierup N. Svensson H. Mulder H. Sundler F. Regul. Pept. 2002; 107: 63-69Crossref PubMed Scopus (363) Google Scholar, 23Wierup N. Yang S. McEvilly R.J. Mulder H. Sundler F. J. Histochem. Cytochem. 2004; 52: 301-310Crossref PubMed Scopus (187) Google Scholar, 24Prado C.L. Pugh-Bernard A.E. Elghazi L. Sosa-Pineda B. Sussel L. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 2924-2929Crossref PubMed Scopus (397) Google Scholar). Although there was no apparent change of plasma insulin levels in ghrelin null mouse (25Sun Y. Ahmed S. Smith R.G. Mol. Cell. Biol. 2003; 23: 7973-7981Crossref PubMed Scopus (544) Google Scholar, 26Wortley K.E. Anderson K.D. Garcia K. Murray J.D. Malinova L. Liu R. Moncrieffe M. K. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: PubMed Scopus Google which may indicate that ghrelin is not a of insulin secretion in the there have been of the effect of of ghrelin on insulin secretion. Broglio et et and et al. have reported that ghrelin has an effect on insulin secretion F. Arvat E. A. C. Muccioli G. Papotti M. Deghenghi R. Ghigo E. J. Clin. Endocrinol. Metab. 2001; PubMed Scopus Google Scholar, J. J. Eur. J. Endocrinol. 2002; PubMed Scopus Google Scholar, G. B. Endocrinology. 2003; PubMed Scopus Google Scholar, F. C. A. F. S. C. M. Deghenghi R. Ghigo E. J. Clin. Endocrinol. Metab. 2003; PubMed Scopus Google Scholar). et Date et and et al. have reported that ghrelin insulin secretion (20Date Y. Nakazato M. Hashiguchi S. Dezaki K. Mondal M.S. Hosoda H. Kojima M. Kangawa K. Arima T. Matsuo H. Yada T. Matsukura S. Diabetes. 2002; 51: 124-129Crossref PubMed Scopus (536) Google Scholar, E. J. 2002; 14: PubMed Scopus Google Scholar, G. Kojima M. G.H. Endocrinology. 2002; 143: PubMed Scopus Google Scholar). et al. have reported ghrelin has and on its concentration A. C. R. Regul. Pept. 2004; PubMed Scopus Google Scholar). there is a of about the of ghrelin in the pancreas and the of ghrelin on the insulin secretion. for the of desacyl ghrelin on insulin secretion, Broglio et al. F. A. C. F. C. L. Arvat E. Deghenghi R. Ghigo E. J. Endocrinol. Invest. 2003; PubMed Scopus Google Scholar) have reported that desacyl ghrelin has no effect on insulin secretion in human that the effect of n-octanoylated ghrelin on insulin secretion with n-octanoylated ghrelin F. C. F. C. Muccioli G. Papotti M. T. Ghigo E. J. Clin. Endocrinol. Metab. 2004; PubMed Scopus Google Scholar). developed and analyzed two types of transgenic mice: rat insulin II promoter-ghrelin transgenic mice (RIP-G Tg) and rat glucagon promoter-ghrelin transgenic mice (RGP-G Tg). The of study was to the effect of transgenic of ghrelin in pancreatic islets. and stomach was from of mouse stomach with a ghrelin was from rat ghrelin as a and mouse ghrelin was The was into the of mice The were into the of mice mice were identified by of the mouse ghrelin as a RGP-G Tg was mice were used as were on rat food on a were by the of on tissue were the as described H. Hosoda K. R. H. C. J. T. Takaya K. Ogawa Y. Hayashi T. Inoue G. Akamizu T. Hosoda H. Kojima M. Kangawa K. M. Nakao K. J. Clin. Endocrinol. Metab. 2002; 87: PubMed Scopus Google Scholar). were and the of was were with ghrelin [13–28] ghrelin [1–11] (1Kojima M. Hosoda H. Date Y. Nakazato M. Matsuo H. Kangawa K. Nature. 1999; 402: 656-660Crossref PubMed Scopus (7317) Google which the n-octanoylated of by E. Y. R. J. G. PubMed Google and by B. Cell. PubMed Scopus Google Scholar) of β cell was in by and for mouse were The of β cell in the pancreas was by the of cells in by the of the of and Ghrelin was from RIP-G Tg and nontransgenic the RGP-G Tg and littermates, was was from the the of the to and and was to the a concentration of of was and ghrelin concentration was by desacyl ghrelin and that n-octanoylated ghrelin for of tissue ghrelin were from the The was from the were and for in the of acid was to so that the concentration was to and the were The were ghrelin concentration was by radioimmunoassay (RIA) anti-ghrelin [13–28] and anti-ghrelin [1–11] as described H. Kojima M. Matsuo H. Kangawa K. Biochem. Biophys. Res. Commun. 2000; PubMed Scopus Google Scholar). of and were and were to rat of mice were measured food was measured by the and of and mice were with and of mice were measured by and the glucose tolerance the mice were with glucose the insulin tolerance a mice were with human insulin was from the and and the glucose levels were by glucose the mice were with glucose was from the and and the The of insulin concentration was by rat insulin for of pancreatic insulin were from the mice the and in The were used for of the in was into mouse pancreatic was and for by islets were by and so that the of the islets were were in for and in glucose and for islets were in of and glucose for the were in were by rat insulin and was from of were were as described H. Hosoda K. R. H. C. J. T. Takaya K. Ogawa Y. Hayashi T. Inoue G. Akamizu T. Hosoda H. Kojima M. Kangawa K. M. Nakao K. J. Clin. Endocrinol. Metab. 2002; 87: PubMed Scopus Google Scholar) the mouse insulin II and human as that of were in the density of in the and of in was The was an was with and II reverse was with The and were mouse mouse ghrelin was from the of RIP-G Tg and nontransgenic littermates. of and levels in were by and were as of in was by of of Ghrelin in which cell type of islet cells ghrelin in mouse by ghrelin the of the islets no immunoreactivity was C-terminal immunoreactivity was in the of of islets of type mice of the cells were by of the cells were not of and and mouse ghrelin was so that ghrelin expression to the pancreatic β cells The ghrelin mRNA level of RIP-G Tg in pancreas by was about times higher than that of nontransgenic was an in ghrelin mRNA levels in of RIP-G Tg the expression of ghrelin in pancreatic β an ghrelin C-terminal immunoreactivity was in the of the islets of the RIP-G Tg was in the of the islets of nontransgenic ghrelin showed the that n-octanoylated ghrelin may in β cells of transgenic We the of RIP-G Tg. immunoreactivity was detected with ghrelin not The pancreatic tissue ghrelin concentration of RIP-G Tg measured by C-RIA was about 1000 times higher than that of nontransgenic concentration was about of the nontransgenic stomach concentration The pancreatic tissue ghrelin concentration of RIP-G Tg measured by to higher than that of nontransgenic not did not desacyl ghrelin concentration of RIP-G Tg was about 3.4 times higher than that of nontransgenic the We measured desacyl ghrelin levels in of the the nontransgenic the desacyl ghrelin level was significantly higher than that in The desacyl ghrelin concentration from of RIP-G Tg the was higher than that of nontransgenic The of desacyl ghrelin concentration from to of RIP-G Tg was significantly higher than that of nontransgenic n-octanoylated ghrelin levels in and of RIP-G Tg to higher than those of nontransgenic did not We RGP-G Tg, in which ghrelin expression is to the pancreatic α cells The ghrelin mRNA level Tg in pancreas of RGP-G by was about times higher than that of nontransgenic The ghrelin mRNA level in of Tg was not different from that of nontransgenic The ghrelin mRNA level in of Tg was not distinguishable from that of nontransgenic showed immunoreactivity in the of the pancreatic islet of transgenic mouse by ghrelin and ghrelin and The pancreatic tissue ghrelin of RGP-G Tg measured by C-RIA were about 50 times higher than those of nontransgenic The pancreatic tissue ghrelin concentration of RGP-G Tg measured by to higher than that of nontransgenic did not The plasma desacyl ghrelin in were not in RGP-G Tg with nontransgenic The desacyl ghrelin of RGP-G Tg were from those of nontransgenic n-octanoylated ghrelin levels in and of RGP-G Tg were from those of nontransgenic and was no significant in and food RIP-G Tg and nontransgenic and of RIP-G Tg were not different from those of nontransgenic and significant changes were in RGP-G Tg, not and no significant in blood glucose levels were RIP-G Tg and nontransgenic on the and glucose tolerance and plasma insulin levels and the glucose were significantly in RIP-G Tg with those in nontransgenic of insulin secretion was not in RIP-G Tg on of glucose level of RIP-G Tg in the insulin tolerance test to lower than those of nontransgenic littermates, did not significant in blood glucose insulin levels were RGP-G Tg and nontransgenic on the glucose and and not glucose levels on insulin tolerance test showed no and nontransgenic not Islet and β the tissue of RIP-G Tg to the effect of ghrelin on the islet and β cell were no in the islet and cell of and PP cells in the islets of the RIP-G Tg The of of these islet in the islets of the RIP-G Tg was not different from those of nontransgenic littermates. The of the β cell to pancreas was not significantly We the tissue of RGP-G Tg and no significant and of mRNA and RIP-G Tg showed suppression of insulin secretion, pancreatic mRNA expression and peptide of insulin in RIP-G Tg and nontransgenic by and The insulin mRNA in RIP-G Tg did not from those of nontransgenic and significant of insulin were RIP-G Tg and nontransgenic PDX-1 and GLUT2 the immunoreactivity of PDX-1 and GLUT2 in RIP-G Tg. The of PDX-1 and GLUT2 in the RIP-G Tg and were not different from those in the nontransgenic and of of due to to high level measured the expression level of mRNA in pancreas and pituitary by were no significant in mRNA levels RIP-G Tg and nontransgenic in pancreas in pituitary of insulin secretion from islet of RIP-G Tg by batch incubation was from that of nontransgenic littermates, in glucose level of RIP-G Tg to lower than those of nontransgenic littermates, did not The plasma triglyceride level of RIP-G Tg to lower than that of nontransgenic littermates, did not acid level and level of RIP-G Tg were not significantly different from those of nontransgenic 3.4 no immunoreactivity was detected in of the islets. C-terminal immunoreactivity was in the of of islets of type which is with a C.L. Pugh-Bernard A.E. Elghazi L. Sosa-Pineda B. Sussel L. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 2924-2929Crossref PubMed Scopus (397) Google Scholar). the of the cells showed indicate that ghrelin was in of mouse pancreatic α of ghrelin was not detected in pancreatic β cells of type the present study developed RIP-G Tg, in which pancreatic ghrelin concentration measured by C-RIA was times higher than that of nontransgenic littermates. ghrelin [13–28] detected C-terminal immunoreactivity in the of islets. ghrelin was not detected in β cells of mice by ghrelin by was to in β We about times higher expression level of ghrelin mRNA in the of RIP-G Tg with that of nontransgenic littermates, which not detected by Although a of ghrelin has been reported to in which detected by (1Kojima M. Hosoda H. Date Y. Nakazato M. Matsuo H. Kangawa K. Nature. 1999; 402: 656-660Crossref PubMed Scopus (7317) Google there have been as to of ghrelin in the has a biological the food of RIP-G Tg was not different from that of nontransgenic littermates, the ghrelin by in the not to show effect of n-octanoylated anti-ghrelin [1–11] that the n-octanoylated of immunoreactivity was in of islets of RIP-G Tg, the of n-octanoylated ghrelin in β that the of may not in pancreatic α cells in β is α and β cells are pancreatic cells from cells A. Endocrine. 2002; PubMed Scopus Google Scholar). the of the pancreatic tissue ghrelin concentration of RIP-G Tg was lower than that of the stomach the of in β cell lower than that of in cell in the stomach is that pancreatic with the these were by The possibility is that of the of ghrelin in the tissue the by anti-ghrelin [1–11] not the as that by the of n-octanoylated ghrelin was so that not detected by RIA that the of these transgenic mice is due to the effect of desacyl ghrelin has been not to H. Kojima M. Matsuo H. Kangawa K. Biochem. Biophys. Res. Commun. 2000; PubMed Scopus Google Scholar). have been that desacyl ghrelin has biological as R. N. T. Endocrinology. 2004; PubMed Scopus Google of cell of G. N. S. F. S. A. G. R. Broglio F. Papotti M. N. F. J. Deghenghi R. F. M. Muccioli G. Ghigo E. A. J. Biol. 2002; PubMed Scopus Google and the effect of n-octanoylated ghrelin F. C. F. C. Muccioli G. Papotti M. T. Ghigo E. J. Clin. Endocrinol. Metab. 2004; PubMed Scopus Google Scholar). We showed that the ghrelin level in is significantly higher than that in in type Ghrelin has been reported to in stomach and The of plasma ghrelin level in gastric has been reported N. T. Kuroiwa T. K. T. Mondal M.S. Nakazato M. Kojima M. Kangawa K. J. Endocrinol. 2002; PubMed Scopus Google there has been no the of plasma ghrelin level in as with that in The present study is the of the of plasma ghrelin levels in the of desacyl ghrelin in RIP-G Tg was higher than that in littermates, of desacyl ghrelin by in the The and food of RIP-G Tg were not significantly different from those of nontransgenic littermates. and et al. have reported the of ghrelin transgenic mouse H. Takaya K. Iwakura H. Hosoda H. Akamizu T. Y. Kangawa K. Nakao K. Endocrinology. PubMed Scopus Google Scholar, A. Inui A. Fujimiya M. R. N. Y. Kasuga M. PubMed Scopus Google in which plasma desacyl ghrelin levels were and 50 times higher than those of nontransgenic littermates. transgenic mice were reported to show of on et al. reported that the triglyceride level of ghrelin transgenic mouse was that level and acid level were not with nontransgenic littermates. The triglyceride levels of RIP-G Tg showed lower tendency with that of nontransgenic littermates. The of and of in RIP-G Tg may from the that plasma desacyl ghrelin level of RIP-G Tg was 3.4 times higher than those of nontransgenic littermates. The tissue of the pancreas of these transgenic mice showed no apparent in the islet and in β cell have been on the transgenic mice in the β as growth and growth A. M.A. J. Biol. 2000; 275: PubMed Scopus Google Scholar, P. A. Endocrinology. PubMed Scopus Google Scholar, K. Murphy J. Endocrinol. PubMed Scopus Google Scholar, J. E. W. Endocrinology. 1999; PubMed Google Scholar). of these transgenic mice showed islet of the cells in the islet A. M.A. J. Biol. 2000; 275: PubMed Scopus Google Scholar, P. A. Endocrinology. PubMed Scopus Google Scholar, K. Murphy J. Endocrinol. PubMed Scopus Google Scholar, J. E. W. Endocrinology. 1999; PubMed Google Scholar). showed that desacyl ghrelin have no apparent on the islet and β cell the present study plasma insulin levels the glucose were significantly lower in RIP-G Tg than those in nontransgenic littermates, there was no significant in plasma insulin levels RIP-G Tg and nontransgenic on the the of insulin by insulin measured insulin mRNA level and in the of transgenic The insulin mRNA level and from the transgenic mice were not significantly different from those from nontransgenic littermates. the insulin not in these mice in The immunoreactivity of which is the of the pancreas and essential for insulin in RIP-G Tg β cell was not different from that in β cells of nontransgenic littermates. results that the suppression of glucose-stimulated insulin secretion in RIP-G Tg not due to the of insulin by of insulin RIP-G Tg did not show secretion in to is to insulin secretion by the that are different from those used by the H. B. N. P. J. PubMed Scopus Google Scholar, K. H. F. PubMed Scopus Google Scholar). that into the β and that to the of P. J. Biol. PubMed Google Scholar, P. Diabetes. PubMed Scopus Google Scholar). the insulin secretion in RIP-G Tg not due to in J. J. Eur. J. Endocrinol. 2002; PubMed Scopus Google Scholar) reported that ghrelin insulin secretion from rat pancreas in to in there has been no on the effect of desacyl ghrelin on insulin secretion. The immunoreactivity of glucose in the pancreatic β in RIP-G Tg β was from that in the β cells of nontransgenic littermates. Although is not so for no apparent expression of GLUT2 in RIP-G Tg β cell to the high level of desacyl ghrelin may not influence on GLUT2 We a batch incubation study of RIP-G Tg islet. The insulin secretion from islets of RIP-G Tg was from that of nontransgenic littermates. that insulin secretion was not by of ghrelin in was in The different in and in may by of ghrelin by with the incubation suppression of insulin secretion of RIP-G Tg was not due to the effect of desacyl ghrelin on insulin secretion from β cell on insulin sensitivity. Recently et al. C. Broglio F. R.J. Ghigo E. J. Clin. Endocrinol. Metab. PubMed Scopus Google Scholar) reported that of desacyl ghrelin and ghrelin insulin in C. T. P. Broglio F. Ghigo E. J. Clin. Endocrinol. Metab. 2004; PubMed Scopus Google Scholar) and that desacyl ghrelin glucose output from Although an insulin tolerance test did not show a significant in blood glucose levels RIP-G Tg and nontransgenic littermates, there was a tendency for lower blood glucose levels of RIP-G Tg. plasma triglyceride levels of RIP-G Tg showed lower these results may indicate that desacyl ghrelin may insulin of RIP-G Tg. The suppression of insulin secretion of RIP-G Tg is likely due to the effect of desacyl ghrelin on insulin sensitivity. to high level desacyl ghrelin may influence the expression level of GHS-R, the mRNA level of in the pancreas and pituitary of RIP-G Tg. significant were in mRNA levels in pancreas in pituitary RIP-G Tg and nontransgenic littermates. indicate that to high level desacyl ghrelin not influence the mRNA expression We developed RGP-G Tg. The pancreatic tissue ghrelin by C-RIA of RGP-G Tg were about 50 times higher than those of nontransgenic littermates, that ghrelin was in RGP-G Tg. there was no insulin secretion and pancreatic the that ghrelin levels were not in RGP-G Tg with those in nontransgenic littermates, the of ghrelin from α cell may not the from developed RIP-G Tg, in which pancreatic desacyl ghrelin was times higher than that in littermates. We detected n-octanoylated immunoreactivity in pancreatic β cells by that the of may not in pancreatic α cells in β The glucose-stimulated insulin secretion of RIP-G Tg was were no with the insulin secretion, pancreatic pancreatic insulin mRNA levels, and insulin in the RIP-G Tg. The of insulin suppression in the islet batch incubation lower tendency of blood glucose levels in insulin tolerance and lower tendency of plasma triglyceride level may indicate that the suppression of insulin secretion of RIP-G Tg is likely due to the effect of desacyl ghrelin on insulin sensitivity. Although developed RGP-G Tg with a of pancreatic desacyl ghrelin did not insulin secretion and pancreatic The present study raises the possibility that desacyl ghrelin may have an influence on glucose metabolism.
54
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Masayasu Kojima, Hiroshi Hosoda, Yukari Date et al. · Nature · 1999 · 8.5K citations
Ghrelin induces adiposity in rodents
Matthias H. Tschöp, David L. Smiley, Mark L. Heiman · Nature · 2000 · 3.9K citations
A role for ghrelin in the central regulation of feeding
Masamitsu Nakazato, Noboru Murakami, Yukari Date et al. · Nature · 2001 · 3.4K citations
Yukari Date, Masayasu Kojima, Hiroshi Hosoda et al. · Endocrinology · 2000 · 1.8K citations
The Novel Hypothalamic Peptide Ghrelin Stimulates Food Intake and Growth Hormone Secretion
Alison Wren, C. J. Small, Helen L. Ward et al. · Endocrinology · 2000 · 1.5K citations